How many pens of liraglutide (glucagon-like peptide-1 receptor agonist) are typically needed for a 1-month supply?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Many Liraglutide Pens Are Needed for One Month

For a one-month supply of liraglutide, patients typically need 2-3 pens depending on the prescribed dose, with each pen containing 3 mL (18 mg) of medication and lasting 15-30 days depending on dosage.

Liraglutide Pen Supply Calculation

Liraglutide (Victoza/Saxenda) is a once-daily injectable GLP-1 receptor agonist that comes in pre-filled pens containing 18 mg/3 mL (6 mg/mL) 1, 2. The number of pens needed per month depends on the prescribed dose:

Dosing and Supply Requirements

  • Starting dose: 0.6 mg once daily for at least 1 week
  • Maintenance dose: 1.2 mg or 1.8 mg once daily
  • For obesity treatment: May be titrated up to 3.0 mg daily

Pen Duration by Dose:

  • At 0.6 mg daily: 1 pen lasts approximately 30 days (30 doses)
  • At 1.2 mg daily: 1 pen lasts approximately 15 days (15 doses)
  • At 1.8 mg daily: 1 pen lasts approximately 10 days (10 doses)
  • At 3.0 mg daily: 1 pen lasts approximately 6 days (6 doses)

Therefore:

  • Patients on 1.2 mg daily need 2 pens per month
  • Patients on 1.8 mg daily need 3 pens per month
  • Patients on 3.0 mg daily need 5 pens per month

Titration Schedule and Impact on Initial Supply

The FDA-approved titration schedule for liraglutide affects the initial month's supply 1:

  • Week 1: 0.6 mg daily
  • Week 2: 1.2 mg daily
  • Week 3: 1.8 mg daily (if needed)
  • Week 4: 2.4 mg daily (for obesity treatment)
  • Week 5+: 3.0 mg daily (for obesity treatment)

During the first month of treatment with titration, patients may need fewer pens than in subsequent months when they reach their maintenance dose.

Important Considerations

  • Each pen should be discarded 30 days after first use, even if medication remains 2
  • Unused pens should be stored in the refrigerator (36°F to 46°F)
  • Pens in use can be stored at room temperature (59°F to 86°F) for up to 30 days 2
  • Liraglutide is administered once daily, independent of meals, at any time of day 3

Common Pitfalls to Avoid

  1. Confusion with weekly GLP-1 RAs: Unlike semaglutide (Ozempic/Wegovy) which is administered weekly, liraglutide requires daily administration 4

  2. Inadequate supply planning: Patients should be prescribed enough pens to cover their entire month at their maintenance dose

  3. Improper storage: Patients should be educated on proper storage requirements to maintain medication efficacy

  4. Premature dose escalation: Titration should follow the recommended schedule to minimize gastrointestinal side effects 1

By ensuring patients have the appropriate number of pens based on their prescribed dose, healthcare providers can help maintain treatment continuity and optimize outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Liraglutide in clinical practice: dosing, safety and efficacy.

International journal of clinical practice. Supplement, 2010

Guideline

Liraglutide Administration Guidelines for Type 2 Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.